Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing glycemic control for surgical patients with type 2 diabetes mellitus
2013-002936-26Phase 4Terminated
- Sponsor
- Christoffer Hedetoft
- Start
- Feb 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of insulin glargine and insulin aspart in type 2 diabetes mellitus (T2DM), sponsored by Christoffer Hedetoft. Primary endpoint: Plasma glucose within target range. Started Feb 2014; status: terminated.
02
Drugs
insulin glargineinsulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2013-002936-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002936-26.